We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Hepatic Resection Can Provide Long-Term Survival

By HospiMedica International staff writers
Posted on 18 Jul 2012
A new study suggests that hepatic resection can provide long–term survival benefit in selected patients with non-early-stage hepatocellular carcinoma (HCC).

Researchers at Kaohsiung Medical University (Taiwan) conducted a study involving 478 patients with HCC who underwent liver resection between 1991 and 2006. More...
Of these, 318 were Barcelona Clinical Liver Cancer Classification (BCLC) stage B, and 160 and BCLC stage C. The researchers examined and analyzed factors involved in overall survival and recurrence. The results showed that after a median follow–up of 29.5 months, 304 of the patients had died, putting the cumulative overall survival rate at five years at 46.5% in BCLC stage B patients, and 29.1% in stage C patients.

Multivariate analysis disclosed that serum albumin levels below or equal to 4 g/dL, indocyanine green retention rate at 15 minutes of over 10%, serum creatinine higher than 1.2 mg/dL, multinodularity, Edmondson stage III or IV in tumor cell differentiation, and the presence of macroscopic vascular invasion were independent risk factors of poor overall survival. There were 331 patients with tumor recurrence after resection, and the recurrence rate was less in BCLC stage B than that in BCLC stage C, and was associated with cut margins smaller than one centimeter. The study was published ahead of print on July 3, 2012, in Surgery.

“Hepatic resection can provide long-term survival benefit in selected BCLC stage B or C patients with compensated liver function, especially in those presenting with a single neoplasm without vascular invasion,” concluded lead author Wen-Tsan Chang, MD, and colleagues of the division of hepatobiliary and pancreatic surgery.

The biggest concern about liver resection is that following the operation, the patient can develop liver failure, which occurs if the remaining portion of the liver is inadequate to provide the necessary support for life. Even in carefully selected patients, about 10% of them are expected to die shortly after surgery, usually because of liver failure. In patients with HCC, liver resection is generally limited to patients with one or two small (5 cm or less) tumors and confined to the liver with no invasion of the blood vessels. As a result of these strict guidelines, in practice, very few patients with HCC can undergo liver resection.

Related Links:

Kaohsiung Medical University




Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.